Abacavir, dolutegravir, and lamivudine and Incruse Ellipta
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Indacaterol
- Abacavir, dolutegravir, and lamivudine-Indacaterol and Glycopyrrolate
- Abacavir, dolutegravir, and lamivudine-Indacaterol and glycopyrrolate Inhalation
- Abacavir, dolutegravir, and lamivudine-Indacaterol inhalation
- Abacavir, dolutegravir, and lamivudine-Indacaterol Maleate
- Abacavir, dolutegravir, and lamivudine-Indapamide
- Incruse Ellipta-Abacavir, Lamivudine and Zidovudine Tablets
- Incruse Ellipta-Abacavir, lamivudine, and zidovudine
- Incruse Ellipta-Abaloparatide
- Incruse Ellipta-Abaloparatide Subcutaneous
- Incruse Ellipta-Abatacept
- Incruse Ellipta-Abatacept Auto-Injectors